“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback